No price history available.
Key financial summary
Financials in HKD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | HKDm | 135,553 | 221,036 | 178,414 | 174,543 | 198,381 | 204,590 | N/A | N/A |
| Operating profit | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | HKDm | 5,036 | 25,961 | 7,541 | 2,547 | 5,323 | 5,857 | N/A | N/A |
| EPS reported | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in HKD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
BOE Technology Group Company Limited, a global Internet of Things (IoT) enterprise established in Beijing, China, in 1993, specializes in delivering advanced intelligent interface products and professional services. These offerings are designed to enhance information interaction and support human well-being across the globe. The company's diverse operations are organized into key segments: Display, IoT Innovation, Sensor and Application Solutions, Mini LED, and Smart Medicine & Engineering. In its Display division, BOE leverages sophisticated technologies such as TFT-LCD, AMOLED Oxide, and Microdisplay. These are integrated into a vast array of products, spanning consumer electronics like smartphones, tablets, laptops, monitors, and televisions, to specialized applications including vehicle displays, electronic shelf labels, tiled screens, industrial control systems, wearable and VR/AR devices, electronic tags, white goods, healthcare equipment, mobile payment systems, and interactive whiteboards. This segment also develops smart terminal products, such as tablets, low-power devices, IoT-specific displays, and 3D displays, complemented by integrated design and manufacturing services for system solutions. BOE's IoT innovation business provides comprehensive hardware and software solutions customized for sectors like smart finance, intelligent park management, government services, transportation, energy, and urban lighting. The Sensor and Application Solutions segment focuses on critical areas including medical biological detection, transportation and construction, consumer electronics, microwave communications, and industrial sensing. Here, BOE excels in designing and manufacturing sensor devices and offering complete system solutions, featuring products such as flat panel X-ray detectors, digital microfluidic chips, PDLC glass, fingerprint identification systems, and various industrial sensors. Furthermore, BOE is a significant provider of Mini-LED backlight and display products. Under its Smart Medicine & Engineering arm, the company is dedicated to advancing digital hospitals, offering holistic health management services, and developing technology-driven healthcare solutions. This includes an IoT platform specifically for smart health management, covering a full spectrum of health services from prevention and treatment to therapy and nursing.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
BOE Technology Group Company Limited (200725.SZ)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
BOE Technology Group Company Limited, a global Internet of Things (IoT) enterprise established in Beijing, China, in 1993, specializes in delivering advanced intelligent interface products and professional services. These offerings are designed to enhance information interaction and support human well-being across the globe. The company's diverse operations are organized into key segments: Display, IoT Innovation, Sensor and Application Solutions, Mini LED, and Smart Medicine & Engineering. In its Display division, BOE leverages sophisticated technologies such as TFT-LCD, AMOLED Oxide, and Microdisplay. These are integrated into a vast array of products, spanning consumer electronics like smartphones, tablets, laptops, monitors, and televisions, to specialized applications including vehicle displays, electronic shelf labels, tiled screens, industrial control systems, wearable and VR/AR devices, electronic tags, white goods, healthcare equipment, mobile payment systems, and interactive whiteboards. This segment also develops smart terminal products, such as tablets, low-power devices, IoT-specific displays, and 3D displays, complemented by integrated design and manufacturing services for system solutions. BOE's IoT innovation business provides comprehensive hardware and software solutions customized for sectors like smart finance, intelligent park management, government services, transportation, energy, and urban lighting. The Sensor and Application Solutions segment focuses on critical areas including medical biological detection, transportation and construction, consumer electronics, microwave communications, and industrial sensing. Here, BOE excels in designing and manufacturing sensor devices and offering complete system solutions, featuring products such as flat panel X-ray detectors, digital microfluidic chips, PDLC glass, fingerprint identification systems, and various industrial sensors. Furthermore, BOE is a significant provider of Mini-LED backlight and display products. Under its Smart Medicine & Engineering arm, the company is dedicated to advancing digital hospitals, offering holistic health management services, and developing technology-driven healthcare solutions. This includes an IoT platform specifically for smart health management, covering a full spectrum of health services from prevention and treatment to therapy and nursing.